Founded in 2010, The END Fund focuses on delivering neglected tropical disease (NTD) treatments to those in need. NTDs are a group of parasitic and bacterial infectious diseases that affect more than 1.7 billion of the world's most impoverished people. The End Fund grows and engages a community of activist-philanthropists, manages high-impact strategic investments, and works in collaboration with government, NGO, pharmaceutical, and academic partners. We aim to take a systems approach to understanding, engaging with, and influencing the broad ecosystem of stakeholders working on ending NTDs.
2 Park Avenue
New York, NY 10016